AORT: Insider sales and 1,513-share vesting
AORT insider filings report proposed and completed transactions in common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
AORT insider filings report proposed and completed transactions in common stock. The filing lists a restricted stock vesting of 1,513 shares on 02/27/2026 described as issuer compensation. It also reports past sales by Marshall S. Stanton of 2,423 shares for $91,074.51 on 02/23/2026 and 1,259 shares for $44,937.36 on 02/24/2026.
Insights
Filing records restricted stock vesting and recent insider sales by a named officer.
The excerpt shows a restricted stock vesting event of 1,513 shares on 02/27/2026 characterized as issuer compensation. It separately documents completed sales by Marshall S. Stanton of 2,423 shares for $91,074.51 on 02/23/2026 and 1,259 shares for $44,937.36 on 02/24/2026.
These entries are routine compensation vesting and reported dispositions; cash‑flow treatment to the issuer versus selling holders is explicit for the sales amounts shown. Subsequent filings or transaction confirmations may provide additional context such as brokerage details or whether the vested shares were subject to lockups.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the AORT Form 144 disclose about restricted stock?
Does the Form 144 indicate who received proceeds from the transactions?
Is the planned sale amount or offering size specified in the AORT excerpt?
AI-generated analysis. How Rhea-AI works. Not financial advice.